Suppr超能文献

SCH 23390,一种选择性多巴胺D1拮抗剂,可激活多巴胺神经元,但无法阻止阿扑吗啡对它们的抑制作用。

SCH 23390, a selective dopamine D1 antagonist, activates dopamine neurons but fails to prevent their inhibition by apomorphine.

作者信息

Mereu G, Collu M, Ongini E, Biggio G, Gessa G L

出版信息

Eur J Pharmacol. 1985 May 20;111(3):393-6. doi: 10.1016/0014-2999(85)90649-1.

Abstract

SCH 23390, a rather selective D1 receptor blocker, activates the firing rate of dopamine (DA) neurons in the substantia nigra (SN-DA neurons) in rats, similarly to haloperidol (a D1-D2 receptor antagonist) and sulpiride (a selective D2 receptor blocker). These neuroleptics produce no additional increase over the maximal activation produced by SCH 23390. Unlike haloperidol or sulpiride, SCH 23390 fails to prevent the inhibition by apomorphine of SN-DA neurons, a DA autoreceptor-mediated effect. It is suggested that the doses of SCH 23390 that stimulate DA neurons block D2 in addition to D1 receptors, or that D1 blockade results in the functional inactivation of a specific population of D2 receptors as well. The failure of SCH 23390 to block the apomorphine effect indicates that DA autoreceptors can be pharmacologically differentiated form postsynaptic DA receptors.

摘要

SCH 23390是一种相当具有选择性的D1受体阻滞剂,它能激活大鼠黑质中多巴胺(DA)神经元(SN-DA神经元)的放电频率,这与氟哌啶醇(一种D1-D2受体拮抗剂)和舒必利(一种选择性D2受体阻滞剂)类似。这些抗精神病药物在SCH 23390产生的最大激活作用基础上不会产生额外的增加。与氟哌啶醇或舒必利不同,SCH 23390无法阻止阿扑吗啡对SN-DA神经元的抑制作用,这是一种DA自身受体介导的效应。有人提出,刺激DA神经元的SCH 23390剂量除了阻断D1受体外还会阻断D2受体,或者D1受体阻断也会导致特定群体的D2受体功能失活。SCH 23390未能阻断阿扑吗啡效应表明,DA自身受体在药理学上可与突触后DA受体区分开来。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验